Recent

% | $
Quotes you view appear here for quick access.

Sorrento Therapeutics, Inc. Message Board

  • zero.risk13 zero.risk13 Dec 17, 2013 3:46 PM Flag

    Nobody Here, They all Went over to GTHP ... the next 10 Bagger

    GTHP's cervical cancer scan has been approved in EU, Asia, Canada
    Imminent FDA approval will blow the roof off.

    Over 60 million annual PAP smear test are taken annually.
    GTHP's biophotonic scan is noninvasive, more accurate and provides instantaneous test results.

    Market cap is only $30 million.

 
SRNE
6.75-0.08(-1.17%)May 4 4:00 PMEDT